FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016552156> ?p ?o ?g. }

• W2016552156 endingPage "621" @default.
• W2016552156 startingPage "613" @default.
• W2016552156 abstract "Therapy with alkylating agents, such as cyclophosphamide, can be associated with irreversible gonadal toxicity in male survivors of adult cancer. To the authors's knowledge the effect of high dose therapy with cyclophosphamide during childhood on adult testicular reproductive and endocrine function has not been established.Gonadal function was studied in 17 adult male survivors of childhood sarcomas treated with high dose pulse cyclophosphamide therapy as part of a VAC (vincristine, actinomycin, and cyclophosphamide) or Adria-VAC (doxorubicin, vincristine, actinomycin, and cyclophosphamide) chemotherapy regimen. Patients answered a questionnaire concerning sexual functioning and underwent a comprehensive physical examination, semen analysis, and hormonal evaluation.Of the 17 males who underwent semen analysis, 10 (58.8%) had azoospermia, 5 (29.4%) had oligospermia, and only 2 (11.8%) were found to have a normal sperm count. All patients treated prior to the onset of puberty had an abnormal semen analysis. The 2 patients with normal sperm counts received the lowest doses of cyclophosphamide (< 7.5 g/m(2)). The baseline follicle-stimulating hormone level was elevated in only 10 of 14 patients with abnormal sperm counts (71.4%). Testosterone levels were normal in 15 of 16 patients (93.8%); however, the baseline luteinizing hormone (LH) level was elevated in 6 of 15 patients with normal testosterone levels (40%). Gonadotropin-releasing hormone-stimulated LH levels were > 3 times that of baseline in 13 of /14 patients (92.9%), suggesting some degree of Leydig cell insufficiency.The results of the current study show a high risk of gonadal dysfunction in men exposed to cyclophosphamide during childhood as part of a VAC/Adria-VAC chemotherapy regimen. Exposure prior to puberty was not found to be protective, and the risk of infertility appeared to increase with higher doses of therapy. To the authors' knowledge the clinical significance of impaired Leydig cell function beginning at a young age is unknown and merits further study." @default.
• W2016552156 created "2016-06-24" @default.
• W2016552156 creator A5002974659 @default.
• W2016552156 creator A5011956202 @default.
• W2016552156 creator A5016016418 @default.
• W2016552156 creator A5019568309 @default.
• W2016552156 creator A5087229168 @default.
• W2016552156 date "2001-01-01" @default.
• W2016552156 modified "2023-10-09" @default.
• W2016552156 title "High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood" @default.
• W2016552156 cites W1862618844 @default.
• W2016552156 cites W1976013921 @default.
• W2016552156 cites W1976686772 @default.
• W2016552156 cites W1978723594 @default.
• W2016552156 cites W1982796459 @default.
• W2016552156 cites W1987328906 @default.
• W2016552156 cites W1989175401 @default.
• W2016552156 cites W2000145425 @default.
• W2016552156 cites W2021616554 @default.
• W2016552156 cites W2022071767 @default.
• W2016552156 cites W2037399376 @default.
• W2016552156 cites W2037548970 @default.
• W2016552156 cites W2040468822 @default.
• W2016552156 cites W2041426853 @default.
• W2016552156 cites W2052966115 @default.
• W2016552156 cites W2058655763 @default.
• W2016552156 cites W2072487355 @default.
• W2016552156 cites W2104604416 @default.
• W2016552156 cites W2134422076 @default.
• W2016552156 cites W2155003421 @default.
• W2016552156 cites W2157596954 @default.
• W2016552156 cites W2163055816 @default.
• W2016552156 cites W2169808607 @default.
• W2016552156 cites W2174319032 @default.
• W2016552156 cites W2175942611 @default.
• W2016552156 cites W2247404961 @default.
• W2016552156 cites W2317789359 @default.
• W2016552156 cites W2334984195 @default.
• W2016552156 cites W2573242028 @default.
• W2016552156 cites W32437444 @default.
• W2016552156 doi "https://doi.org/10.1002/1097-0142(20010201)91:3<613::aid-cncr1042>3.0.co;2-r" @default.
• W2016552156 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11169946" @default.
• W2016552156 hasPublicationYear "2001" @default.
• W2016552156 type Work @default.
• W2016552156 sameAs 2016552156 @default.
• W2016552156 citedByCount "275" @default.
• W2016552156 countsByYear W20165521562012 @default.
• W2016552156 countsByYear W20165521562013 @default.
• W2016552156 countsByYear W20165521562014 @default.
• W2016552156 countsByYear W20165521562015 @default.
• W2016552156 countsByYear W20165521562016 @default.
• W2016552156 countsByYear W20165521562017 @default.
• W2016552156 countsByYear W20165521562018 @default.
• W2016552156 countsByYear W20165521562019 @default.
• W2016552156 countsByYear W20165521562020 @default.
• W2016552156 countsByYear W20165521562021 @default.
• W2016552156 countsByYear W20165521562022 @default.
• W2016552156 countsByYear W20165521562023 @default.
• W2016552156 crossrefType "journal-article" @default.
• W2016552156 hasAuthorship W2016552156A5002974659 @default.
• W2016552156 hasAuthorship W2016552156A5011956202 @default.
• W2016552156 hasAuthorship W2016552156A5016016418 @default.
• W2016552156 hasAuthorship W2016552156A5019568309 @default.
• W2016552156 hasAuthorship W2016552156A5087229168 @default.
• W2016552156 hasBestOaLocation W20165521561 @default.
• W2016552156 hasConcept C126322002 @default.
• W2016552156 hasConcept C126894567 @default.
• W2016552156 hasConcept C134018914 @default.
• W2016552156 hasConcept C16685009 @default.
• W2016552156 hasConcept C2776694085 @default.
• W2016552156 hasConcept C2776755627 @default.
• W2016552156 hasConcept C2777420699 @default.
• W2016552156 hasConcept C2777589648 @default.
• W2016552156 hasConcept C2777688143 @default.
• W2016552156 hasConcept C2778575703 @default.
• W2016552156 hasConcept C2779234561 @default.
• W2016552156 hasConcept C2779279165 @default.
• W2016552156 hasConcept C2779279991 @default.
• W2016552156 hasConcept C2781087480 @default.
• W2016552156 hasConcept C42407357 @default.
• W2016552156 hasConcept C54355233 @default.
• W2016552156 hasConcept C71315377 @default.
• W2016552156 hasConcept C71924100 @default.
• W2016552156 hasConcept C86803240 @default.
• W2016552156 hasConceptScore W2016552156C126322002 @default.
• W2016552156 hasConceptScore W2016552156C126894567 @default.
• W2016552156 hasConceptScore W2016552156C134018914 @default.
• W2016552156 hasConceptScore W2016552156C16685009 @default.
• W2016552156 hasConceptScore W2016552156C2776694085 @default.
• W2016552156 hasConceptScore W2016552156C2776755627 @default.
• W2016552156 hasConceptScore W2016552156C2777420699 @default.
• W2016552156 hasConceptScore W2016552156C2777589648 @default.
• W2016552156 hasConceptScore W2016552156C2777688143 @default.
• W2016552156 hasConceptScore W2016552156C2778575703 @default.
• W2016552156 hasConceptScore W2016552156C2779234561 @default.
• W2016552156 hasConceptScore W2016552156C2779279165 @default.
• W2016552156 hasConceptScore W2016552156C2779279991 @default.
• W2016552156 hasConceptScore W2016552156C2781087480 @default.

• next